Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Slagelsekiropraktoren ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   9.3% 7.9% 10.9% 9.0% 9.8% 11.4% 18.6% 18.2%   Credit score (0-100)   28 31 21 26 24 21 7 8   Credit rating   BB BB BB BB BB BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,894 2,548 2,930 2,558 2,768 2,747 0.0 0.0   EBITDA   270 72.7 139 28.0 245 76.7 0.0 0.0   EBIT   153 -10.3 27.1 -15.1 187 43.1 0.0 0.0   Pre-tax profit (PTP)   152.7 -11.4 22.8 -16.2 186.2 43.7 0.0 0.0   Net earnings   117.4 -9.5 17.2 -13.0 145.1 33.7 0.0 0.0   Pre-tax profit without non-rec. items   153 -11.4 22.8 -16.2 186 43.7 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   123 115 73.9 39.5 18.7 5.9 0.0 0.0   Shareholders equity total   660 540 444 317 462 356 276 276   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   940 941 743 474 723 566 276 276   Net Debt   -373 -407 -208 -101 -315 -291 -276 -276     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,894 2,548 2,930 2,558 2,768 2,747 0.0 0.0   Gross profit growth   12.4% -12.0% 15.0% -12.7% 8.2% -0.8% -100.0% 0.0%   Employees   8 7 7 8 7 6 0 0   Employee growth %   14.3% -12.5% 0.0% 14.3% -12.5% -14.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   940 941 743 474 723 566 276 276   Balance sheet change%   22.5% 0.2% -21.1% -36.2% 52.6% -21.7% -51.3% 0.0%   Added value   269.9 72.7 138.9 28.0 230.0 76.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -161 -91 -153 -78 -79 -46 -6 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 -1.0 1.0 -1.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   5.3% -0.4% 0.9% -0.6% 6.8% 1.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   18.0% -1.1% 3.2% -2.5% 31.2% 7.0% 0.0% 0.0%   ROI %   25.0% -1.7% 5.5% -4.0% 48.0% 11.0% 0.0% 0.0%   ROE %   19.5% -1.6% 3.5% -3.4% 37.2% 8.2% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   70.3% 57.4% 59.8% 66.9% 63.9% 62.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -138.1% -559.6% -149.8% -359.2% -128.6% -378.9% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   2.6 1.8 1.9 2.1 2.3 2.1 0.0 0.0   Current Ratio   2.6 1.8 1.9 2.1 2.3 2.2 0.0 0.0   Cash and cash equivalent   372.8 407.0 208.2 100.6 315.0 290.6 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   439.5 326.7 272.5 177.4 337.2 242.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   34 10 20 4 33 13 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   34 10 20 4 35 13 0 0   EBIT / employee   19 -1 4 -2 27 7 0 0   Net earnings / employee   15 -1 2 -2 21 6 0 0